Cargando…

A novel fatty-acid metabolism-based classification for triple negative breast cancer

Background: The high heterogeneity of triple negative breast cancer (TNBC) is the main clinical challenge for individualized therapy. Considering that fatty acid metabolism (FAM) plays an indispensable role in tumorigenesis and development of TNBC, we proposed a novel FAM-based classification to cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Xia, Tang, Wen, He, Yongtao, An, Huimin, Wang, Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008496/ https://www.ncbi.nlm.nih.gov/pubmed/36880837 http://dx.doi.org/10.18632/aging.204552

Ejemplares similares

Correction for: A novel fatty-acid metabolism-based classification for triple negative breast cancer
por: Yang, Xia, et al.
Publicado: (2023)

Fatty acid synthetase expression in triple-negative breast cancer
por: Park, Jin Hee, et al.
Publicado: (2022)

Triple-Negative Breast Cancer Analysis Based on Metabolic Gene Classification and Immunotherapy
por: Zhou, Yu, et al.
Publicado: (2022)

Dipalmitoylphosphatidic acid inhibits tumor growth in triple-negative breast cancer
por: Zhang, Qian-Qian, et al.
Publicado: (2017)

Classification of triple-negative breast cancers based on Immunogenomic profiling
por: He, Yin, et al.
Publicado: (2018)

Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer
por: Giró-Perafita, Ariadna, et al.
Publicado: (2017)

Molecular Classification of Triple-Negative Breast Cancer
por: Ahn, Sung Gwe, et al.
Publicado: (2016)

Differences in elongation of very long chain fatty acids and fatty acid metabolism between triple-negative and hormone receptor-positive breast cancer
por: Yamashita, Yuji, et al.
Publicado: (2017)

MYC regulates fatty acid metabolism through a multigenic program in claudin-low triple negative breast cancer
por: Casciano, Jessica C., et al.
Publicado: (2020)

Identified the novel resistant biomarkers for taxane-based therapy for triple-negative breast cancer
por: Chou, Ching-Wen, et al.
Publicado: (2021)

HRD1 inhibits fatty acid oxidation and tumorigenesis by ubiquitinating CPT2 in triple‐negative breast cancer
por: Guo, Xin, et al.
Publicado: (2020)

In Vivo Optical Metabolic Imaging of Long-Chain Fatty Acid Uptake in Orthotopic Models of Triple-Negative Breast Cancer
por: Madonna, Megan C., et al.
Publicado: (2021)

Dandelion extract inhibits triple-negative breast cancer cell proliferation by interfering with glycerophospholipids and unsaturated fatty acids metabolism
por: Wang, Shan, et al.
Publicado: (2022)

Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism
por: Wang, Shengting, et al.
Publicado: (2023)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

Inhibition of cannabinoid receptor type 1 sensitizes triple-negative breast cancer cells to ferroptosis via regulating fatty acid metabolism
por: Li, Pengyun, et al.
Publicado: (2022)

Association between fatty acid synthase and adipophilin expression in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2022)

Comparison of Clinicopathological Features and Prognosis in Triple-Negative and Non-Triple Negative Breast Cancer
por: Qiu, Jingdan, et al.
Publicado: (2016)

Triple Negative Breast Cancer: Updates on Classification and Treatment in 2021
por: Bou Zerdan, Maroun, et al.
Publicado: (2022)

The nature of triple-negative breast cancer classification and antitumoral strategies
por: Kim, Songmi, et al.
Publicado: (2020)

Targeting Metabolic Remodeling in Triple Negative Breast Cancer in a Murine Model
por: García-Castillo, Verónica, et al.
Publicado: (2017)

Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
por: Camarda, Roman, et al.
Publicado: (2016)

Metabolic characterization of triple negative breast cancer
por: Cao, Maria D, et al.
Publicado: (2014)

Metabolic Reprogramming in Triple-Negative Breast Cancer
por: Sun, Xiangyu, et al.
Publicado: (2020)

Metabolic reprogramming in triple-negative breast cancer
por: Wang, Zhanyu, et al.
Publicado: (2020)

Attempt towards a novel classification of triple-negative breast cancer using immunohistochemical markers
por: Liu, Yan-Xi, et al.
Publicado: (2016)

LncRNAs as new biomarkers to differentiate triple negative breast cancer from non-triple negative breast cancer
por: Lv, Mingming, et al.
Publicado: (2016)

Identification of novel long non-coding RNAs in triple-negative breast cancer
por: Shen, Xiaokun, et al.
Publicado: (2015)

Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft
por: Bharti, Santosh K., et al.
Publicado: (2018)

Identification of a novel glycolysis-related prognosis risk signature in triple-negative breast cancer
por: Ruan, Yuxia, et al.
Publicado: (2023)

Immune Classification and Immune Landscape Analysis of Triple-Negative Breast Cancer
por: Hu, Shaojun, et al.
Publicado: (2021)

A novel immune subtype classification of ER-positive, PR-negative and HER2-negative breast cancer based on the genomic and transcriptomic landscape
por: Xie, Peiling, et al.
Publicado: (2021)

Molecular classification of triple-negative tumors
por: Prat, A, et al.
Publicado: (2011)

Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells
por: Rushing, Blake R., et al.
Publicado: (2023)

The Clinicopathological Features and Survival Outcomes of Different Histological Subtypes in Triple-negative Breast Cancer
por: Liao, Hong-Ye, et al.
Publicado: (2018)

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies
por: Marra, Antonio, et al.
Publicado: (2020)

Reduced Expression of Annexin A6 Induces Metabolic Reprogramming That Favors Rapid Fatty Acid Oxidation in Triple-Negative Breast Cancer Cells
por: Williams, Stephen D., et al.
Publicado: (2022)

Sustained IP3-linked Ca(2+) signaling promotes progression of triple negative breast cancer cells by regulating fatty acid metabolism
por: Filadi, Riccardo, et al.
Publicado: (2023)

Cripto-1 as a novel therapeutic target for triple negative breast cancer
por: Castro, Nadia P., et al.
Publicado: (2014)

The paracrine effects of adipocytes on lipid metabolism in doxorubicin-treated triple negative breast cancer cells
por: Mentoor, Ilze, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bbn7fvplnqs118adsmk61te84b